Actively Recruiting
Study of STIM1 Membrane Expression
Led by University Hospital, Brest · Updated on 2025-02-06
670
Participants Needed
4
Research Sites
311 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM. This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.
CONDITIONS
Official Title
Study of STIM1 Membrane Expression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of one of the autoimmune diseases
You will not qualify if you...
- Treatment with rituximab in the previous 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
CHRU de Brest - Service de rhumatologie
Brest, Brest, France, 29200
Actively Recruiting
2
Centre Hospitalier des Pays de Morlaix
Morlaix, Brittany Region, France, 29672
Actively Recruiting
3
Centre Hospitalier de Quimper
Quimper, Brittany Region, France, 29000
Actively Recruiting
4
CHU de Martinique
Fort-de-France, Martinique, France, 97261
Actively Recruiting
Research Team
D
Divi Cornec
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
18
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here